Hochster Underscores Headway Made in Gastric/GEJ Cancers
Season 6, Episode 18, Dec 16, 2021, 08:49 PM
Dr. Hochster provides insight into the current gastric/GEJ landscape, spotlighting molecular testing approaches, the roles of chemoimmunotherapy combinations, ongoing research with biomarkers of response, and optimal treatment sequencing for patients with HER2-positive disease.